Back

Early experience utilizing bivalirudin as anticoagulation in extracorporeal membrane oxygen in coronavirus disease 2019

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: COVID-19 and cardiovascular pharmacotherapy Anticoagulants ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Can Jones

HCA Florida JFK Hospital, West Palm Beach (United States of America)

4 More presentations in this session

Presentation thumbnail
Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis.
Doctor A. Pani (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).
Doctor F. Santoro (Foggia, IT)
Abstract Slides Video
Presentation thumbnail
Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients
Doctor C. Diaz-Arocutipa (Lima, PE)
Abstract Slides Video
Presentation thumbnail
Management and impact of atrial fibrillation in the COVID 19 era; concomitancy of two procoagulant phenomena
Doctor A. Arteagoitia Bolumburu (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
COVID-19 and cardiovascular pharmacotherapy

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources